The estimated Net Worth of Venture Partners Vii L.P.De... is at least $181 Tausend dollars as of 6 November 2017. Venture De owns over 36,000 units of Allena Pharmaceuticals Inc stock worth over $181,069 and over the last 7 years Venture sold ALNA stock worth over $0.
Sign up
Venture De ALNA stock SEC Form 4 insiders trading
Venture has made over 1 trades of the Allena Pharmaceuticals Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Venture bought 36,000 units of ALNA stock worth $504,000 on 6 November 2017.
The largest trade Venture's ever made was buying 36,000 units of Allena Pharmaceuticals Inc stock on 6 November 2017 worth over $504,000. On average, Venture trades about 36,000 units every 0 days since 2017. As of 6 November 2017 Venture still owns at least 2,263,365 units of Allena Pharmaceuticals Inc stock.
You can see the complete history of Venture De stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Insiders trading at Allena Pharmaceuticals Inc
Over the last 7 years, insiders at Allena Pharmaceuticals Inc have traded over $0 worth of Allena Pharmaceuticals Inc stock and bought 1,537,428 units worth $21,523,992 . The most active insiders traders include Andrew A. F. Hack, James N Topper und Harbor Master Investors (Ca.... On average, Allena Pharmaceuticals Inc executives and independent directors trade stock every 134 days with the average trade being worth of $15,887. The most recent stock trade was executed by Louis Md Brenner on 15 November 2021, trading 125,582 units of ALNA stock currently worth $10,047.
What does Allena Pharmaceuticals Inc's logo look like?
Complete history of Venture De stock trades at Allena Pharmaceuticals Inc
Allena Pharmaceuticals Inc executives and stock owners
Allena Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Louis Brenner,
President, Chief Executive Officer, Director -
Edward Wholihan,
Chief Financial Officer -
Dr. Louis Brenner,
Pres, CEO & Director -
Dr. Alexey L. Margolin,
Co-Founder & Chairman -
Alexey Margolin,
Chairman of the Board, Co-Founder -
Geoffrey Swire,
Acting Chief Operating Officer, Interim Principal Operating Officer, Senior Vice President - Corporate Development -
James Topper,
Independent Director -
Gino Santini,
Independent Director -
Andrew Hack,
Independent Director -
Allene Diaz,
Independent Director -
Robert Alexander,
Independent Director -
Ann Miller,
Director -
Stephen Yu,
Sr. VP of Corp. Quality -
Dr. David J. Clark,
Chief Medical Officer -
Alicja Januszewicz Ph.D.,
VP of People & Culture -
Hugh Wight,
Sr. VP of Technical Operations -
Dr. Richard D. Katz,
CFO, Principal Financial Officer & Principal Accounting Officer -
Robert Gallotto,
Co-Founder & Strategic Adviser -
Bio Capital Ii Lp Hbm,
10% owner -
Robert I Tepper,
Director -
Vi, L.L.C.Fhm Vi, L.P.Frazi...,
-
Harbor Master Investors (Ca...,
10% owner -
Venture Partners Vii L.P.De...,
-
Stephen Kraus,
Director -
Rock Ventures Ii, L.P.Third...,
-
Axel Bolte,
Director -
Richard D Katz,
Chief Financial Officer -
Mark J. Fitzpatrick,
Director